Wavrin, France

Thierry Burnouf


 

Average Co-Inventor Count = 2.3

ph-index = 7

Forward Citations = 281(Granted Patents)


Location History:

  • Wavrin, FR (1993 - 2000)
  • Aubers, FR (2000 - 2009)

Company Filing History:


Years Active: 1993-2009

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: Thierry Burnouf: Innovator in Plasma Treatment Technologies

Introduction

Thierry Burnouf is a notable inventor based in Wavrin, France. He has made significant contributions to the field of plasma treatment technologies, holding a total of 8 patents. His work focuses on methods that enhance the safety and efficacy of plasma products, particularly in reducing viral contamination.

Latest Patents

One of his latest patents is a viral reduction method for plasma using a leukocyte-reduction filter and two virus-reduction filters of decreasing pore diameters. This invention relates to a plasma product or serum product that has an extremely low risk of viral contamination. The method involves removing leukocytes from the blood before treating plasma or serum with a virus removal membrane. This innovative approach allows for the efficient production of plasma products while preventing clogging, enabling effective filtration without the need for elevated pressure.

Career Highlights

Throughout his career, Thierry Burnouf has worked with several organizations, including the Centre Régional De Transfusion Sanguine De Lille and the Association Pour L'Essor De La Transfusion Sanguine Dans La Région Du. His expertise in the field has led to advancements that significantly improve the safety of blood products.

Collaborations

Thierry has collaborated with notable colleagues such as Miryana Burnouf-Radosevich and Dominique Dernis. Their combined efforts have contributed to the development of innovative solutions in the field of transfusion medicine.

Conclusion

In summary, Thierry Burnouf is a distinguished inventor whose work in plasma treatment technologies has made a lasting impact on the field. His innovative methods and collaborations continue to enhance the safety of plasma products, showcasing his commitment to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…